Fracture risk assessment in Latin America: is Frax an adaptable instrument for the region?

Osteoporosis is a generalized disease of bone that increases fracture risk. Multiple factors influence this risk, besides low bone mass. To decrease osteoporotic fractures, those patients who require preventive management should be readily identified. This paper aims to review current information on the use of the fracture risk assessment tool (FRAX) in Latin America. Bone mineral density measurement is currently the method of reference for evaluating the fracture risk and opting for treatment; but, it misses a notable proportion of individuals who have clinical risk factors for osteoporosis and fractures. FRAX was designed to predict the 10-year absolute risk of sustaining a major osteoporotic fracture or a hip fracture. Although data is available for several countries, from Latin America, only Argentina appears in the current version of the tool. Its present use in other Latin American countries is possible with some adaptations based in similarities of epidemiological information of each country with some of the existing databases. The cutoff value beyond which treatment should be initiated needs to be determined, based not only on clinical criteria, but also on economic considerations.

Risks factors for low bone mineral density in pre-menopausal Mexican women with systemic lupus erythematosus

The aim of this study was to determine the prevalence and risk factors for low bone mineral density (BMD) in women with systemic lupus erythematosus (SLE). A cross-sectional study was conducted among 100 pre-menopausal patients with SLE. Patients were evaluated using a questionnaire about the following variables: age, disease duration, disease activity, chronic disease damage, cumulative corticosteroid dose, and history of fracture. Lumbar spine and hip measurements of BMD were performed by dual absorptiometry. Univariate and multivariate statistical analyses were used to assess the relationship between risk factors and BMD. The mean age was 32.8 +/- 8.7 years, and the median duration of SLE was 73.2 +/- 65 months. The mean cumulative corticosteroid dose was 20.0 +/- 21.3 g. The mean BMD was 1.09 +/- .18 g/cm(2) in the lumbar spine and 1.0 +/- .14 g/cm(2) in the hip. Osteopenia was present in 40% of patients and osteoporosis in 5%. In the multiple regression analysis, low BMD in the lumbar spine was associated with chronic disease damage and low body mass index (BMI). Low BMD in the hip was associated with cumulative corticosteroid dose and low BMI. Chronic disease damage, low BMI, and cumulative corticosteroid dose are risks factors for low BMD in pre-menopausal SLE patients. Osteopenia was found in 40% of patients, while osteoporosis was found in only 5%.

[Osteoporosis in Mexican postmenopausal women. Magnitude of the problem. Multicenter study]

Incidencia of osteoporosis induced fractures increases with age; risk increases exponentially as bone mass decreases. Women are prone to osteoporosis 2 to 3 times more than men, due to lower "peak" bone mass and the accelerated loss that occurs after the menopause. The prevalence of osteoporosis in with Caucasian postmenopausal women varies from 16 to 30% depending upon the number of sites measured (lumbar spine/hip and/or forearm). The aim of this study was to estimate the prevalence of osteopenia and osteoporosis in pre and postmenopausal Mexican women in relation to men, and to that reported in Caucasia women. The study involved 4,821 apparently healthy subjects (without known risk factors for osteoporosis), 4,467 females and 354 males from 11 different centers of Mexican Republic, 20 to 90 years old, using DXA bone densitometry of lumbar spine and hip. Prevalence of osteoporosis in women is twice that in men (P < 0.001), and it increases with age, particularly after the menopause (P < 0.0001). Our study found a prevalence of osteoporosis of the lumbar spine and/or hip in apparently healthy postmenopausal Mexican women over 50 years of age of 16%, increasing to 20% in those women with or without risk factors who attended voluntarily or by suggestion of their physician to be studied. The prevalence values obtained seem to be lower than those reported for Caucasian women, 30%. We found a prevalence of osteoporosis of 16% and of osteopenia of 57% in women 50 years of age and older. We also found a higher prevalence of osteoporosis in women of the south east part of the county.